Menu
Home
Forums
Forums
Quick Links
Search Forums
Recent Posts
job listings
catering
whistleblower info
legal help
advertise on CP
submit press release
Menu
Log in
Sign up
Search titles only
Posted by Member:
Separate names with a comma.
Newer Than:
Search this thread only
Search this forum only
Display results as threads
More...
Useful Searches
Recent Posts
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Amgen
>
Enbrel ex-McKinsey nerd
>
Reply to Thread
Name:
Verification:
Answer the above question:
(
CustomImgCaptcha
By
Surrey Forum
)
Message:
<p>[QUOTE="anonymous, post: 5907038"]Enbrel won't get parity coverage, but will still bleed sales just to be covered at all. Congratulate the reimbursement folks when you see them. </p><p><br /></p><p>They're killing future value of the biosimilar market with the deep discounts that will be expected copycats. Someone from the biosimilar brand team should be screaming murder before launch.[/QUOTE]</p><p><br /></p>
[QUOTE="anonymous, post: 5907038"]Enbrel won't get parity coverage, but will still bleed sales just to be covered at all. Congratulate the reimbursement folks when you see them. They're killing future value of the biosimilar market with the deep discounts that will be expected copycats. Someone from the biosimilar brand team should be screaming murder before launch.[/QUOTE]
Your name or email address:
Do you already have an account?
No, create an account now.
Yes, my password is:
Forgot your password?
Stay logged in
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Amgen
>
Enbrel ex-McKinsey nerd
>
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Amgen
>
Enbrel ex-McKinsey nerd
>